Atlas Trials

MedPacto, Inc.

10 clinical trials · Sponsor

Sort:Newest firstOldest first

◉ Watch MedPacto, Inc.

RecordFirmDate
Study to Assess Safety and Efficacy of Vactosertib in Adolescents and Adults With Recurrent, Refractory or Progressive Osteosarcoma (NCT05588648)MedPacto, Inc.2023-05-01
Vactosertib and Imatinib Combination in Patients with Advanced Desmoid Tumor/aggressive Fibromatosis (DT/AF) (NCT06219733)MedPacto, Inc.2021-06-01
Vactosertib in Combination with Pembrolizumab for PD-L1 Positive Non-small Cell Lung Cancer (NSCLC) Subjects (NCT04515979)MedPacto, Inc.2020-12-17
Vactosertib with Durvalumab in Urothelial Carcinoma Failing Checkpoint Inhibition (NCT04064190)MedPacto, Inc.2019-12-13
Phase 1b/2a, Open-label Study of Vactosertib in Combination With Durvalumab in Advanced NSCLC (NCT03732274)MedPacto, Inc.2019-02-11
TEW-7197 with Paclitaxel for the Treatment of Metastatic Gastric Cancer (NCT03698825)MedPacto, Inc.2018-08-15
Effect of Food on the Pharmacokinetics of TEW-7197 in Healthy Subjects (NCT03704675)MedPacto, Inc.2018-08-08
Dose Escalation and Proof-of-Concept Studies of Vactosertib (TEW-7197) Monotherapy in Patients With MDS (NCT03074006)MedPacto, Inc.2018-01-04

Track MedPacto, Inc. automatically

Every clearance here is in the API, with alerts when new ones post.